2013
DOI: 10.1093/nar/gkt401
|View full text |Cite
|
Sign up to set email alerts
|

VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies

Abstract: With the rapid accumulation of our knowledge on diseases, disease-related genes and drug targets, network-based analysis plays an increasingly important role in systems biology, systems pharmacology and translational science. The new release of VisANT aims to provide new functions to facilitate the convenient network analysis of diseases, therapies, genes and drugs. With improved understanding of the mechanisms of complex diseases and drug actions through network analysis, novel drug methods (e.g., drug reposi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
109
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 124 publications
(109 citation statements)
references
References 30 publications
0
109
0
Order By: Relevance
“…Modules containing ≥30 genes were included in our analyses. For module visualization, we used the publically available VisANT software (Hu et al 2013). To determine the reliability of the WGCNA module characterization and the DEGs, we performed a permutation test randomizing 1000 times the expression data associated with each gene, calculated the DEGs, and then applied the same module characterization.…”
Section: Rna-seq Data Analysismentioning
confidence: 99%
“…Modules containing ≥30 genes were included in our analyses. For module visualization, we used the publically available VisANT software (Hu et al 2013). To determine the reliability of the WGCNA module characterization and the DEGs, we performed a permutation test randomizing 1000 times the expression data associated with each gene, calculated the DEGs, and then applied the same module characterization.…”
Section: Rna-seq Data Analysismentioning
confidence: 99%
“…Researchers are now developing approaches that analyze genetic associations in the context of networks and pathways to prioritize potential drugs (16)(17)(18)(19)(20)(21). There is not yet a standard approach or set of techniques that are widely applied, so we highlight examples of the types of techniques being employed.…”
Section: Pathway and Network-based Drug Identification From Genetic Amentioning
confidence: 99%
“…Metagraphs are less restricted than compound graphs and allow representing biological networks more accurately. They have been used to visualize cellular networks at different granularitiesfrom high level networks among groups of molecules to low level networks describing the relationships among individual molecules within and outside of each group [57,58].…”
Section: Metagraphsmentioning
confidence: 99%